U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07814976) titled 'Hyoscine Butylbromide During Transcystic Papillary Balloon Dilation for Choledocholithiasis' on Sept. 04.
Brief Summary: The purpose of the PAPRELAX study is to evaluate the intraoperative effect of intravenous hyoscine butylbromide during laparoscopic transcystic balloon dilation of the papilla of Vater in adult patients undergoing surgical treatment for choledocholithiasis.
The study will evaluate whether administration of hyoscine butylbromide influences the duration of transcystic papillary balloon dilation and the balloon inflation pressure required for papillary dilation.
Eligible participants enrolled prospectively will re...